Cytopenia after CAR-T Cell Therapy—A Brief Review of a Complex Problem

SIMPLE SUMMARY: Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy has emerged as a new life-saving treatment modality in patients with relapsed or refractory B-cell malignancies and multiple-myeloma. In this form of therapy, patient’s T-cells are modified by various genetic techniques to expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Naman, Reagan, Patrick M., Liesveld, Jane L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946106/
https://www.ncbi.nlm.nih.gov/pubmed/35326654
http://dx.doi.org/10.3390/cancers14061501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946106/
https://www.ncbi.nlm.nih.gov/pubmed/35326654
http://dx.doi.org/10.3390/cancers14061501

Ejemplares similares